Back to News
Market Impact: 0.42

Piper Sandler raises Microsoft stock price target on Azure growth

MSFTSMCIAPP
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsArtificial IntelligenceCompany FundamentalsCapital Returns (Dividends / Buybacks)
Piper Sandler raises Microsoft stock price target on Azure growth

Microsoft delivered Q3 revenue of $82.9B and EPS of $4.27, both ahead of consensus ($81.29B and $4.05), with Azure growth of 39% year over year in constant currency. Piper Sandler raised its price target to $540 from $500, citing the stronger Azure outlook, while Microsoft guided Q4 Azure growth to 39.5% versus 36.9% expected and reiterated major AI-related momentum from Copilot, OpenAI, and Anthropic. The company also guided 2026 capex to $190B, reinforcing a heavy but growth-supported AI investment cycle.

Analysis

The market is rewarding Microsoft less for a single quarter than for evidence that its capital intensity is still compounding into durable cloud share gains. The key second-order read is that sustained double-digit capex into a still-accelerating Azure platform makes Microsoft a rare mega-cap where earnings quality is improving even as reported margins are temporarily suppressed; that supports multiple expansion, not just EPS compounding. The upgrade cycle also suggests sell-side models may still be underestimating how much AI attach rates can offset slower legacy seat growth over the next 4-6 quarters. The competitive implication is more interesting than the headline: Microsoft’s scale in cloud + AI raises the hurdle for both hyperscale rivals and model providers that need distribution, compute, and enterprise trust. The biggest beneficiaries are likely adjacent infrastructure vendors and software layers that ride Microsoft spending without bearing the full execution risk; the biggest loser is any enterprise software vendor relying on a slower Copilot monetization curve to justify premium multiples. If capacity additions in the second half of 2026 materialize, the market may start pricing a step-up in revenue inflection before margin recovery, which can keep the stock bid even if near-term operating leverage looks muted. The contrarian risk is that investors are extrapolating demand-side strength while underweighting supply-side dilution: $190B of capex is enormous, and if AI workload economics fail to compress fast enough, returns on incremental capacity could disappoint. That would show up with a lag of multiple quarters, not immediately, so the trade is about owning the rerating now while the burden of proof sits on the bears. Near term, the main catalyst is continued Azure upside versus consensus; the main failure mode is guidance conservatism turning into a growth deceleration narrative once capacity timing slips.